1-20 of 33
Irum Khan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Impact of Air Pollutants on a Chicagoland Cohort of Patients with Acute Myeloid Leukemia

Andrew Palmer, Garth Rauscher, Ivy Abraham, Madelyn Burkart, Ami Dave, Nepheli Raptis, Ahmed Aleem, Vedavyas Gannamani, Amani Erra, Sarah Monick, Carlos Galvez, Melissa L. Larson, Maryam Zia, Stephanie B. Tsai, Jessica K. Altman, Wendy Stock, Irum Khan, Anand Ashwin Patel
Journal: Blood
Blood (2023) 142 (Supplement 1): 3806.
https://doi.org/10.1182/blood-2023-178265
Published: 2023
Journal Articles

Impact of Socioeconomic Disparities on Outcomes in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia

Daniel J Olivieri, Megan Othus, Corentin Orvain, Eduardo Rodríguez-Arbolí, Filippo Milano, Brenda M. Sandmaier, Irum Khan, Chris Davis, Ryan S. Basom, Frederick R. Appelbaum, Roland B. Walter
Journal: Blood
Blood (2023) 142 (Supplement 1): 3809.
https://doi.org/10.1182/blood-2023-181244
Published: 2023
Journal Articles

Individual-Level Social Determinants of Health (SDOH) Measures and Treatment Complications in Acute Leukemia

Eshana Shah, Ana Maria Avila Rodriguez, Jerry W Luo, Joanna Cwykiel, Tasha Chasson, Elizabeth Raigoza, Alexander Bratslavsky, Peter Doukas, Reanna Williams, Christa Jackowicz, Hyein Lee, Talha Khan, Kimberly Webb, Yasmin Abaza, Jessica K. Altman, Betina Yanez, John Quigley, Carlos Galvez, Shira N. Dinner, Kim Johnson, Madelyn Burkart, Irum Khan
Journal: Blood
Blood (2023) 142 (Supplement 1): 374.
https://doi.org/10.1182/blood-2023-189024
Published: 2023
Journal Articles

A Mixed Methods Study to Examine the Influence of Structural Racism on Treatment in Acute Myeloid Leukemia

Eshana Shah, Ana Maria Avila, Jerry W Luo, Tasha Chasson, Elizabeth Raigoza, Ana Gordon, Michael Berbaum, Agatha Gallo, Irum Khan
Journal: Blood
Blood (2022) 140 (Supplement 1): 5262–5263.
https://doi.org/10.1182/blood-2022-159727
Published: 2022
Journal Articles

Safety and Efficacy of the Addition of the Protein Translation Inhibitor Omacetaxine to Induction with Cytarabine and Idarubicin in Newly Diagnosed AML

Samin Houshyar, Betul Gok Yavuz, Pritesh Patel, Nadim Mahmud, Karen Sweiss, Irum Khan, Santosh L. Saraf, Damiano Rondelli, Anwar Khan, John G. Quigley
Journal: Blood
Blood (2022) 140 (Supplement 1): 5957–5958.
https://doi.org/10.1182/blood-2022-170100
Published: 2022
Journal Articles

Measures of Structural Racism Predict ICU Admission Following Intensive Chemotherapy for AML

Ivy Abraham, Garth Rauscher, Anand Ashwin Patel, Sarah Monick, Madelyn Burkhart, Eshana Shah, Ami Dave, Matthew Kroll, Stephanie B. Tsai, Stephanie Berg, Amani Erra, Vedavyas Gannamani, Maryam Zia, Melissa L. Larson, Wendy Stock, Jessica K. Altman, Irum Khan
Journal: Blood
Blood (2022) 140 (Supplement 1): 6061–6063.
https://doi.org/10.1182/blood-2022-166907
Published: 2022
Journal Articles

A Phase Ib Study of the Safety and Efficacy of Venetoclax When Combined with Escalating Doses of Omacetaxine in Patients with Relapsed/Refractory Acute Myeloid Leukemia Failing Treatment with Venetoclax-Containing Regimens (VEN-OM)

Ana Maria Avila, Saad Arain, Karen Sweiss, Pritesh Patel, Samin Houshyar, Gregory S Calip, Irum Khan, Paul G. Rubinstein, Chukwuemeka Uzoka, John G. Quigley
Journal: Blood
Blood (2022) 140 (Supplement 1): 11774–11775.
https://doi.org/10.1182/blood-2022-165565
Published: 2022
Journal Articles

Structural racism is a mediator of disparities in acute myeloid leukemia outcomes

Clinical Trials & Observations
Ivy Elizabeth Abraham, Garth H. Rauscher, Anand Ashwin Patel, William B. Pearse, Priya Rajakumar, Madelyn Burkart, Ahmed Aleem, Ami Dave, Sushma Bharadwaj, Koosha Paydary, Maria Acevedo-Mendez, Krishna Goparaju, Richard Gomez, Kylie Carlson, Stephanie B. Tsai, John G. Quigley, John P. Galvin, Maryam Zia, Melissa L. Larson, Stephanie Berg, Wendy Stock, Jessica K. Altman, Irum Khan
Journal: Blood
Blood (2022) 139 (14): 2212–2226.
https://doi.org/10.1182/blood.2021012830
Published: 2022
Includes: Supplemental data
Journal Articles

Isoform Selective HDAC8 Inhibitor (OCH3) Shows Potency in Selectively Targeting Primary AML Cells

Amal Mechaal, Amudha Ganapathy, Dolores Mahmud, Taha Y Taha, Rajeev Ranjan, Irum Khan, Pavel Petukhov, Nadim Mahmud
Journal: Blood
Blood (2021) 138 (Supplement 1): 2944.
https://doi.org/10.1182/blood-2021-151599
Published: 2021
Journal Articles

Structural and Social Barriers to Survival in Adolescent and Young Adult (AYA) Patients with Acute Myeloid Leukemia (AML)

Madelyn Burkart, Ivy Abraham, Garth Rauscher, Nepheli Raptis, Maryam Zia, Anand Ashwin Patel, Ami Dave, Stephanie Berg, Wendy Stock, Melissa L. Larson, William B Pearse, Jessica K. Altman, Irum Khan, Shira Dinner
Journal: Blood
Blood (2021) 138 (Supplement 1): 844.
https://doi.org/10.1182/blood-2021-151677
Published: 2021
Journal Articles

Hematologic Predictors of Outcomes in Patients Undergoing Intensive Induction Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia

Saad Arain, MD, Eshana Shah, MD, Betul Gok Yavuz, MD PhD, Sarah Stettner, Gregory Sampang Calip, PharmD,MPH,PhD, Irum Khan, MD, Pritesh Patel, MB, ChB, John G. Quigley
Journal: Blood
Blood (2020) 136 (Supplement 1): 39–40.
https://doi.org/10.1182/blood-2020-136708
Published: 2020
Journal Articles

The Role of Structural Violence in Acute Myeloid Leukemia Outcomes

Ivy Abraham, MD, Garth Rauscher, PhD MPH, Anand Ashwin Patel, MD, William B Pearse, MD, Priya Rajakumar, MD, Stephanie Berg, DO, Ahmed Aleem, MD, Ami Dave, MD, Sushma Bharadwaj, MD, Koosha Paydary, MD, Maria Acevedo-Mendez, Richard Gomez, Kylie Carlson, Stephanie B. Tsai, MD MS, Jessica K. Altman, MD, Wendy Stock, MD, John G. Quigley, Maryam Zia, MD, Melissa C. Larson, MD, Irum Khan, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10.
https://doi.org/10.1182/blood-2020-136379
Published: 2020
Journal Articles

Role of Racial, Demographic and Socioeconomic Disparities in Treatment Patterns and Outcomes in AML

Ivy Abraham, MD, Garth Rauscher, PhD MPH, Anand Ashwin Patel, MD, Wendy Stock, MD, Maryam Zia, MD, Sushma Bharadwaj, MD, Koosha Paydary, MD, Maria Acevedo-Mendez, John P Galvin, MDMS,MPH, William Pearse, MD, Jessica K. Altman, John G. Quigley, Priya Rajakumar, MD, Melissa L. Larson, MD, Irum Khan, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3413.
https://doi.org/10.1182/blood-2019-124974
Published: 2019
Journal Articles

An Open-Label, Phase 2 Study of KRT-232, a First-in-Class, Oral Small Molecule Inhibitor of MDM2, for the Treatment of Patients with Myelofibrosis (MF) Who Have Previously Received Treatment with a JAK Inhibitor

Regina Garcia-Delgado, MD, Donal P. McLornan, MB, BCh (Hons), MRCP, PhD FRCPath, László Rejtő, Eric Jourdan, MD, Haifa Kathrin Al-Ali, MD, Andrzej Pluta, MD, Marek Hus, MD PhD, Joanne Ewing, PhDBMBS BSc FRPATH, Irum Khan, MD, Holger Hebart, Philipp J. Jost, MD, Sebastian Grosicki, MD PhD, Wayne M. Rothbaum, Jesse McGreivy, Srdan Verstovsek, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2945.
https://doi.org/10.1182/blood-2019-123836
Published: 2019
Journal Articles

Impact of Race on Outcomes in Intermediate Risk Acute Myeloid Leukemia

Ivy Abraham, MD, Anand Ashwin Patel, MD, Yanyu Zhang, Li C Liu, PhD, Olga Frankfurt, MD, Irum Khan, MBBS
Journal: Blood
Blood (2018) 132 (Supplement 1): 3603.
https://doi.org/10.1182/blood-2018-99-115156
Published: 2018
Journal Articles

A Safety Study of the Addition of Omacetaxine to the Standard-of-Care Induction Regimen of Cytarabine and Idarubicin in Newly-Diagnosed AML Patients

Sonia Christian, MD, Kelley E. Kozma, DO, Stephanie Barath, Ardaman Shergill, MD, Damiano Rondelli, MD, David Peace, MD, Santosh L. Saraf, MD, Annie Lee Oh, MD, Karen Sweiss, PharmD, Irum Khan, MBBS, Pritesh Patel, MD, Arkadiusz Dudek, MD PhD, John G. Quigley
Journal: Blood
Blood (2018) 132 (Supplement 1): 5218.
https://doi.org/10.1182/blood-2018-99-111412
Published: 2018
Journal Articles

Evaluation of Romyelocel-L Myeloid Progenitor Cells to Decrease Infections in De Novo AML Patients Receiving High-Dose Ara-C-Based Induction Therapy

Farhad Ravandi, MD, Camille N Abboud, MD, Luke Paul Akard, MD, Saar I. Gill, MDPhD, Jack W. Hsu, MD, Suman Kambhampati, MD, Irum Khan, MBBS, Delong Liu, MD PhD, Wendy Stock, MD, Janice W Brown, MD, Asad Bashey, MD PhD, Gautam Borthakur, MD, Courtney D. DiNardo, MDMSc, H. Kent Holland, MD, Tapan M. Kadia, MD, Hagop M. Kantarjian, MD, Lawrence E Morris, MD, Scott R Solomon, MD, Richard David Mamelok, MD, Swapna Panuganti, PhD, Rod Van Syoc, Alicia Wong, BS, Deborah Zimmerman, PhD, Melhem Solh, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1407.
https://doi.org/10.1182/blood-2018-99-117231
Published: 2018
Journal Articles

Impact of Leukapheresis and Time to Chemotherapy on Outcomes of Newly Diagnosed Patients (pts) with Acute Myeloid Leukemia (AML) Presenting with Hyperleukocytosis: An Analysis from a Large International Patient Cohort

Maximilian Stahl, MD, Wei Wei, MD PhD, Pau Montesinos, MD PhD, Etienne Lengline, MD, Rory M Shallis, MD, Judith Neukirchen, MD, Vijaya R. Bhatt, MD, Mikkael A. Sekeres, MD MS, Amir T. Fathi, MD, Heiko Konig, MDPhD, Selina Luger, MD, Irum Khan, MBBS, Gail J. Roboz, MD, Thomas Cluzeau, MD PhD, David Martínez-Cuadron, MD, Emmanuel Raffoux, MD, Ulrich Germing, MD, Jayadev Manikkam Umakanthan, MBBS, Sudipto Mukherjee, MD PhD MPH, Andrew M. Brunner, MD, Adam M. Miller, BS, MD, Christine M. McMahon, MD, Ellen K. Ritchie, MD, Rebeca Rodríguez-Veiga, MD, Raphael Itzykson, MD PhD, Blanca Boluda, MD, Florence Rabian, MD, Mar Tormo, MD, Evelyn Gloria Acuna Cruz, MD, Emma Rabinovich, MD, Brendan Yoo, Nikolai A. Podoltsev, MD PhD, Steven D. Gore, MD, Amer M. Zeidan, MBBS, MHS
Journal: Blood
Blood (2018) 132 (Supplement 1): 1428.
https://doi.org/10.1182/blood-2018-99-112495
Published: 2018
Journal Articles

A Multi-Institution Comparison of Mitoxantrone, Etoposide and Cytarabine (MEC) Vs High-Dose Cytarabine and Mitoxantrone (Ara-C Couplets) Therapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia

Sonia Christian, MD, Pritesh Patel, MD, Vaibhav Agrawal, MD MBA, Shawn Griffin, PharmD, Kirk Cahill, MD, Irum Khan, MBBS, Karen Sweiss, PharmD, Ardaman Shergill, MD, Gregory Sampang Calip, PharmD,MPH,PhD, Wendy Stock, MD, Olatoyosi Odenike, MD, Heiko Konig, MDPhD, John G. Quigley
Journal: Blood
Blood (2018) 132 (Supplement 1): 1397.
https://doi.org/10.1182/blood-2018-99-111389
Published: 2018
Journal Articles

Characteristics, Treatment Patterns and Outcomes Among Newly Diagnosed Patients (pts) with Acute Myeloid Leukemia (AML) Who Present with Hyperleukocytosis: Findings from a Large International Patient Cohort

Maximilian Stahl, MD, Wei Wei, MD PhD, Pau Montesinos, MD PhD, Etienne Lengline, MD, Rory M Shallis, MD, Judith Neukirchen, MD, Vijaya R. Bhatt, MD, Mikkael A. Sekeres, MD MS, Amir T. Fathi, MD, Heiko Konig, MD PhD, Selina Luger, MD, Irum Khan, MBBS, Gail J. Roboz, MD, Thomas Cluzeau, MD PhD, David Martínez-Cuadron, MD, Emmanuel Raffoux, MD, Ulrich Germing, MD, Jayadev Manikkam Umakanthan, MBBS, Sudipto Mukherjee, MD PhD MPH, Andrew M. Brunner, MD, Adam M. Miller, BS, MD, Christine M. McMahon, MD, Ellen K. Ritchie, MD, Rebeca Rodríguez-Veiga, MD, Raphael Itzykson, MD PhD, Blanca Boluda, MD, Florence Rabian, MD, Mar Tormo, MD, Evelyn Gloria Acuna Cruz, MD, Emma Rabinovich, MD, Brendan Yoo, Nikolai A. Podoltsev, MD PhD, Steven D. Gore, MD, Amer M. Zeidan, MBBS, MHS
Journal: Blood
Blood (2018) 132 (Supplement 1): 4040.
https://doi.org/10.1182/blood-2018-99-112974
Published: 2018